GPC2-CAR T cells tuned for low antigen density mediate potent
Por um escritor misterioso
Descrição
Pediatric cancers often mimic fetal tissues and express proteins normally silenced postnatally that could serve as immune targets. We developed T cell…
Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma - ScienceDirect
D3-GPC2-PBD is potently cytotoxic to GPC2-expressing SCLCs (A)
Frontiers Adoptive Cell Therapy in Pediatric and Young Adult Solid Tumors: Current Status and Future Directions
Frontiers Fine-tuning the antigen sensitivity of CAR T cells: emerging strategies and current challenges
CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice - ScienceDirect
Mechanisms of Resistance and Treatment of Relapse after CAR T-cell Therapy for Large B-cell Lymphoma and Multiple Myeloma - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and
PDF) Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma
Frontiers Fine-tuning the antigen sensitivity of CAR T cells: emerging strategies and current challenges
Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma
Present Status and Advances in Chimeric Antigen Receptor T Cell Therapy for Glioblastoma
GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity - ScienceDirect
CAR-T Therapies in Solid Tumors: Opportunities and Challenges
CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models, Journal of Experimental & Clinical Cancer Research
de
por adulto (o preço varia de acordo com o tamanho do grupo)
